Michael Maggio
Psychiatric/Mental Health · Warren, OHNPI 1417501412
Payments from drug & device makers
Across 251 payments — averaging $17.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Supernus Pharmaceuticals, Inc.$559
- Otsuka America Pharmaceutical, Inc.$417
- Alkermes, Inc.$332
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$331
- Corium, LLC$284
- plus $2K from 12 others
What the payments were for
- Food & beverage$4,38399%
- Education$651%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 61 | $1,025 |
| Supernus Pharmaceuticals, Inc. | 42 | $559 |
| Otsuka America Pharmaceutical, Inc. | 21 | $417 |
| Alkermes, Inc. | 14 | $332 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 18 | $331 |
| Corium, LLC | 16 | $284 |
| Axsome Therapeutics, Inc. | 11 | $281 |
| Ironshore Pharmaceuticals Inc. | 15 | $275 |
| Lundbeck LLC | 11 | $195 |
| Vanda Pharmaceuticals Inc. | 9 | $186 |
| Neurocrine Biosciences, Inc. | 9 | $140 |
| Johnson & Johnson | 5 | $123 |
| Tris Pharma Inc | 7 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $104 |
| Avion Pharmaceuticals | 2 | $39 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Almatica Pharma LLC | 1 | $14 |
How this compares
$4,448 in reported general payments places this provider in the 85th percentile of 1,808 psychiatric/mental health providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 19 | $25,208 |
| Imipramine Pamoate | 13 | $1,746 |
| Fluvoxamine Maleate | 20 | $684 |
| Risperidone | 12 | $538 |
| Buspirone Hcl | 27 | $386 |
| Quetiapine Fumarate | 52 | $326 |
| Olanzapine | 19 | $314 |
| Hydroxyzine Hcl | 14 | $220 |
| Sertraline Hcl | 32 | $217 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 43 | $208 |
| Lamotrigine | 17 | $185 |
| Alprazolam | 15 | $166 |
| Diazepam | 24 | $161 |
| Paroxetine Hcl | 11 | $145 |
| Trazodone Hcl | 55 | $122 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $1,025 | $25,20819 claims |
| Almatica Pharma LLCSertraline Hcl | $14 | $21732 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,808 psychiatric/mental health providers in Ohio.
Other psychiatric/mental health in Warren
- Mary HallWarren$195K
- Zachary AldridgeWarren$44K
- Rachelle SchneiterWarren$15K
- Crystal TravisJackson$333K
- Kristina RoweIronton$253K
- Patricia SparksPortsmouth$210K
- Kassandra KornbauCanfield$170K
- Terri PopovitzCincinnati$161K
- Steven MatesDayton$121K
- Robert ParsonsYoungstown$119K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.